Lixin Guo
-
- Diabetes Treatment and Management 41
- Diabetes Management and Research 21
- Diabetes, Cardiovascular Risks, and Lipoproteins 7
- Thyroid Disorders and Treatments 6
- Genetics top 10%
- Diabetes and associated disorders 7
- Physiology top 10%
-
- Metabolism, Diabetes, and Cancer 29
- Bone Metabolism and Diseases 5
-
- Pharmacology and Obesity Treatment 10
- Journals
- Blood (1 paper)The Journal of Clinical Endocrinology & Metabolism (1 paper)Diabetes (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Lixin Guo
98 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Endocrinology, Diabetes and Metabolism 634
- Genetics 237
- Physiology 210
- Industrial and Manufacturing Engineering 64
- Molecular Biology 462
Countries citing papers authored by Lixin Guo
This map shows the geographic impact of Lixin Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lixin Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lixin Guo more than expected).
Fields of papers citing papers by Lixin Guo
This network shows the impact of papers produced by Lixin Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lixin Guo. The network helps show where Lixin Guo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lixin Guo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 9 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 5 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 0 | |
| 8 | 2023 | 7 | |
| 9 | 2023 | 1 | |
| 10 | 2022 | 8 | |
| 11 | 2022 | 8 | |
| 12 | 2021 | 4 | |
| 13 | 2021 | 21 | |
| 14 | 2020 | 5 | |
| 15 | 2020 | 3 | |
| 16 | 2019 | 24 | |
| 17 | 2017 | 10 | |
| 18 | 2016 | 3 | |
| 19 | 2015 | 11 | |
| 20 | Diabetes and osteoporosis. | 2009 | 1 |
About Lixin Guo
Lixin Guo is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology and Cardiology and Cardiovascular Medicine, having authored 110 papers that have together received 1.5k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (41 papers), Metabolism, Diabetes, and Cancer (29 papers), Diabetes Management and Research (21 papers), Pharmacology and Obesity Treatment (10 papers), Diabetes and associated disorders (7 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers), Thyroid Disorders and Treatments (6 papers) and Bone Metabolism and Diseases (5 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (634 citations), Genetics (237 citations) and Physiology (210 citations). Lixin Guo has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Qi Pan, Weihao Wang, Linong Ji, Xiaoxia Wang, Weiping Jia, Jianping Weng, Zhiguang Zhou, Yiming Mu, Dalong Zhu and Xiaoping Luo. Their work appears in journals such as Blood, The Journal of Clinical Endocrinology & Metabolism and Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.